Overview Dividends

(RKLB) Rocket Lab USA - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7731211089

Launch Vehicles, Spacecraft Components, On-Orbit

RKLB EPS (Earnings per Share)

EPS Growth (3Y CAGR): -51.50%
EPS Trend (3Y Correlation): -45.1%

RKLB Revenue

Revenue Growth (3Y CAGR): 35.19%
Revenue Trend (3Y Correlation): 93.5%

Description: RKLB Rocket Lab USA October 14, 2025

Rocket Lab Corporation (NASDAQ:RKLB) is a U.S.-based aerospace firm that offers end-to-end launch and space-systems services, ranging from the design and manufacture of small- and medium-class rockets to on-orbit constellation management for commercial, prime-contractor, and government customers.

Its flagship vehicle, the Electron rocket, has logged over 30 successful missions as of Q3 2024, supporting a growing small-sat market; the company is also progressing with the larger, reusable Neutron launch vehicle, which is slated for its first flight in 2025 and targets mega-constellation and potential crewed missions.

Key performance indicators show a revenue run-rate of roughly $210 million in FY 2024, driven by a 45 % year-over-year increase in launch contracts and a backlog exceeding $1 billion-metrics that reflect the broader industry trend of rising demand for low-cost, high-frequency access to low-Earth orbit, especially from satellite-constellation operators and defense agencies.

For a deeper, data-rich assessment of Rocket Lab’s valuation dynamics and how they compare to peers, a quick look at ValueRay’s analytical dashboards can provide the quantitative context you need.

RKLB Stock Overview

Market Cap in USD	31,245m
Sub-Industry	Industrial Machinery & Supplies & Components
IPO / Inception	2021-08-24

RKLB Stock Ratings

Growth Rating	76.8%
Fundamental	33.6%
Dividend Rating	-
Return 12m vs S&P 500	349%
Analyst Rating	4.13 of 5

RKLB Dividends

Currently no dividends paid

RKLB Growth Ratios

Growth Correlation 3m	86.3%
Growth Correlation 12m	77.6%
Growth Correlation 5y	17.7%
CAGR 5y	131.05%
CAGR/Max DD 3y (Calmar Ratio)	2.36
CAGR/Mean DD 3y (Pain Ratio)	5.40
Sharpe Ratio 12m	1.90
Alpha	423.10
Beta	2.151
Volatility	70.92%
Current Volume	11463.5k
Average Volume 20d	22149.4k
Stop Loss	57 (-7.1%)
Signal	-0.13

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (-231.3m TTM) > 0 and > 6% of Revenue (6% = 30.3m TTM)

FCFTA -0.13 (>2.0%) and ΔFCFTA -0.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 124.9% (prev 148.6%; Δ -23.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.07 (>3.0%) and CFO -110.8m > Net Income -231.3m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 2.67 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (515.1m) change vs 12m ago 4.23% (target <= -2.0% for YES)

Gross Margin 29.04% (prev 25.04%; Δ 4.00pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 36.78% (prev 27.48%; Δ 9.30pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -30.66 (EBITDA TTM -185.7m / Interest Expense TTM 7.19m) >= 6 (WARN >= 3)

Altman Z'' -1.54

(A) 0.41 = (Total Current Assets 1.01b - Total Current Liabilities 376.5m) / Total Assets 1.55b

(B) -0.61 = Retained Earnings (Balance) -940.7m / Total Assets 1.55b

(D) -1.09 = Book Value of Equity -940.0m / Total Liabilities 864.7m

Total Rating: -1.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 33.58

1. Piotroski 2.0pt = -3.0

2. FCF Yield -0.66% = -0.33

3. FCF Margin -40.47% = -7.50

4. Debt/Equity 0.72 = 2.25

5. Debt/Ebitda 0.36 = 2.40

6. ROIC - WACC (= -39.58)% = -12.50

7. RoE -48.14% = -2.50

8. Rev. Trend 93.53% = 7.01

9. EPS Trend -45.13% = -2.26

What is the price of RKLB shares?

As of November 04, 2025, the stock is trading at USD 61.34 with a total of 11,463,477 shares traded.
Over the past week, the price has changed by -6.52%, over one month by +9.22%, over three months by +37.72% and over the past year by +445.24%.

Is Rocket Lab USA a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Rocket Lab USA (NASDAQ:RKLB) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 33.58 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RKLB is around 60.29 USD . This means that RKLB is currently overvalued and has a potential downside of -1.71%.

Is RKLB a buy, sell or hold?

Rocket Lab USA has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy RKLB.

Strong Buy: 7
Buy: 3
Hold: 5
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the RKLB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	58.7	-4.4%
Analysts Target Price	58.7	-4.4%
ValueRay Target Price	70.4	14.7%

RKLB Fundamental Data Overview October 27, 2025

Market Cap USD = 31.24b (31.24b USD * 1.0 USD.USD)
P/S = 61.9607
P/B = 36.8833
Beta = 2.151
Revenue TTM = 504.3m USD
EBIT TTM = -220.4m USD
EBITDA TTM = -185.7m USD
Long Term Debt = 400.2m USD (from longTermDebt, last quarter)
Short Term Debt = 16.5m USD (from shortTermDebt, last quarter)
Debt = 498.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -65.9m USD (from netDebt column, last quarter)
Enterprise Value = 31.05b USD (31.24b + Debt 498.1m - CCE 688.1m)
Interest Coverage Ratio = -30.66 (Ebit TTM -220.4m / Interest Expense TTM 7.19m)
FCF Yield = -0.66% (FCF TTM -204.1m / Enterprise Value 31.05b)
FCF Margin = -40.47% (FCF TTM -204.1m / Revenue TTM 504.3m)
Net Margin = -45.87% (Net Income TTM -231.3m / Revenue TTM 504.3m)
Gross Margin = 29.04% ((Revenue TTM 504.3m - Cost of Revenue TTM 357.8m) / Revenue TTM)
Gross Margin QoQ = 32.10% (prev 28.76%)
Tobins Q-Ratio = 19.99 (Enterprise Value 31.05b / Total Assets 1.55b)
Interest Expense / Debt = 0.48% (Interest Expense 2.37m / Debt 498.1m)
Taxrate = -4.63% (negative due to tax credits) (2.94m / -63.5m)
NOPAT = -230.6m (EBIT -220.4m * (1 - -4.63%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 2.67 (Total Current Assets 1.01b / Total Current Liabilities 376.5m)
Debt / Equity = 0.72 (Debt 498.1m / totalStockholderEquity, last quarter 688.5m)
Debt / EBITDA = 0.36 (negative EBITDA) (Net Debt -65.9m / EBITDA -185.7m)
Debt / FCF = 0.32 (negative FCF - burning cash) (Net Debt -65.9m / FCF TTM -204.1m)
Total Stockholder Equity = 480.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.89% (Net Income -231.3m / Total Assets 1.55b)
RoE = -48.14% (Net Income TTM -231.3m / Total Stockholder Equity 480.5m)
RoCE = -25.02% (EBIT -220.4m / Capital Employed (Equity 480.5m + L.T.Debt 400.2m))
RoIC = -25.85% (negative operating profit) (NOPAT -230.6m / Invested Capital 892.0m)
WACC = 13.73% (E(31.24b)/V(31.74b) * Re(13.94%) + D(498.1m)/V(31.74b) * Rd(0.48%) * (1-Tc(-0.05)))
Discount Rate = 13.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.85%
Fair Price DCF = unknown (Cash Flow -204.1m)
EPS Correlation: -45.13 | EPS CAGR: -51.50% | SUE: -2.94 | # QB: 0
Revenue Correlation: 93.53 | Revenue CAGR: 35.19% | SUE: 4.0 | # QB: 1

Additional Sources for RKLB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle